Assessment of inflammatory bowel disease risk prior to commencing IL‐17 inhibitors: A cross sectional analysis of Irish practice

Authors

Institutions

Publication Details

Journal
JEADV Clinical Practice
Published
2024-11-08
DOI
https://doi.org/10.1002/jvc2.579
Primary Topic
Microscopic Colitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of inflammatory bowel disease risk prior to commencing IL‐17 inhibitors: A cross sectional analysis of Irish practice

Susan M. O’Gorman, Claire Quigley, Lisa Murphy, Amy Long
JEADV Clinical Practice
Microscopic Colitis
article

Assessment of inflammatory bowel disease risk prior to commencing IL‐17 inhibitors: A cross sectional analysis of Irish practice

Susan M. O’Gorman, Claire Quigley, Lisa Murphy, Amy Long
article en

Abstract

No abstract available for this paper.
JEADV Clinical PracticeVol. 4(1)
St. James's Hospital (IE)
Good health and well-being
Openalex Percentile: Top 70%
Microscopic Colitis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Assessment of inflammatory bowel disease risk prior to commencing IL‐17 inhibitors: A cross sectional analysis of Irish practice — Susan M. O’Gorman, Claire Quigley, et al. · JEADV Clinical Practice (2024) | TGRS Research Map | TGRS